Editorial Open Access
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Nov 26, 2018; 10(11): 191-195
Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.191
Thin and crush: The new mantra in left main stenting?
Gianluca Rigatelli, Section of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo 45100, Italy
Marco Zuin, Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara 44124, Italy
Debradata Dash, Interventional Cardiology, Thumbay Hospital, Ajman 415555, United Arab Emirates
ORCID number: Gianluca Rigatelli (0000-0002-7318-3640); Marco Zuin (0000-0002-4559-1292); Debabrata Dash (0000-0003-1354-3808).
Author contributions: Rigatelli G, Zuin M and Dash D conceived the study and drafted the manuscript; all authors approved the final version of the article.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author to: Gianluca Rigatelli, FACC, FACP, MD, PhD, Assistant Professor, Section of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Viale Tre Martiri 140, Rovigo 45100, Italy. jackyheart@libero.it
Telephone: +39-42-5394509 Fax: +39-42-5394513
Received: July 11, 2018
Peer-review started: July 11, 2018
First decision: August 2, 2018
Revised: August 23, 2018
Accepted: October 9, 2018
Article in press: October 9, 2018
Published online: November 26, 2018

Abstract

Complex bifurcations have been suggested to be better approached by a planned double stent technique; however, recent randomized trials have shown better outcomes of provisional compared to planned two-stent strategy, in terms of both short-term efficacy and safety. In left main (LM) bifurcations, double kissing (DK)-Crush has demonstrated its superiority over Culotte and provisional-T in terms of restenosis and stent thrombosis, gaining respect as one of the most performant techniques for bifurcations stenting. On the other hand, the Nano-Crush technique has recently become part of the repertoire of double stenting techniques, providing evidence that the use of ultrathin strut stents and very minimal crush would be beneficial for both the physiological and rheological properties of the complex bifurcations, even in LM scenario, leading to a lower rate of thrombosis and restenosis at both side branch and true carina. Finally, the newest generation of ultrathin strut stents are gaining a reputation for its safe and effective use in LM treatment thanks to improved design with increased expansion rate capable of LM treatment up to 5-6 mm diameter. The modern crush techniques, such as DK-Crush and Nano-Crush, are providing excellent results on mid and long-term follow up, suggesting that minimal crushing obtained using ultra-thin stents is a good way to obtain surgical-like outcomes in the treatment of complex LM bifurcation disease.

Key Words: Coronary bifurcation, Interventional cardiology, Percutaneous coronary intervention, Stent, Crush

Core tip: Modern crush techniques such as DK-Crush and Nano-Crush are providing excellent results on mid and long-term follow-up, suggesting that minimal crushing obtained using ultra-thin stents is a good way to obtain surgical-like outcomes in the treatment of complex left main bifurcation disease.



INTRODUCTION

Complex bifurcations have been suggested to be better approached by a planned double stent technique[1-2], although recent randomized trials have shown better outcomes of provisional compared to planned two-stent strategy in terms of both short-term efficacy and safety[3-4].The total amount of metal layers at both the carina and bifurcation angle after double stenting techniques[5-6] appeared to be important issues to achieve favorable short- and long-term outcomes.

Left main (LM) bifurcation disease is probably the only real important bifurcation in the human vascular tree. The DEFINITION trial[7] has given a practical definition of what is complex and what it is not in the treatment of coronary artery bifurcation disease. Indeed, a length of the left circumflex coronary artery (LCx) > 10 mm has already been identified as a predictor of complex LM bifurcation probably requiring a double stenting strategy.

To achieve similar or better post-procedural results guaranteed by surgical treatment from a rheolytic point of view, the use of intravenous ultrasound is mandatory[8] to properly assess the size and length of the disease in both branches and in the LM body, allowing an accurate selection of the most appropriate stenting technique and stents.

Culotte, mini-Culotte, DK-Crush, T-stent and Protrusion (TAP) are currently the most used double stenting techniques (Table 1)[9]. Recently, DK-Crush has demonstrated its superiority over Culotte[10] and provisional-T[11] techniques in terms of restenosis and stent thrombosis, gaining respect as one of the most performant techniques for bifurcation stenting.

Table 1 Available techniques for left main interventions.
Single stentDouble stent
Cross over-provisionalT-stenting
T and protrusion
Mini-Crush
Culotte and Mini-culotte
DK crush
Nano-Crush

Even more recently, the Nano-Crush technique[12-13] has become part of the repertoire of double stenting techniques, providing evidence that the use of ultrathin strut stents and very minimal crush is beneficial for both the physiological and rheological properties of the complex bifurcations, leading to a lower rate of thrombosis and restenosis at both side branch (SB) and true carina[14].

TECHNICAL COMPARISON AMONG NANO-CRUSH, DK-CRUSH AND OTHERS

Compared to the classical Crush technique introduced by Colombo et al[15], both the Nano- and DK–Crush represent a further modern development of the former. Both these latter techniques require wiring and pre-dilation of both branches and in both SB stenting before main branch (MB) stenting. A different strand is represented by the entity of the SB stent protrusion, which is minimal, with only one ring if possible, in the Nano-Crush, while it appears greater, with at least 3-4 mm of protrusion, in the DK-Crush technique.

Protrusion length of the SB stent explains why kissing is required when DK-Crush is adopted. In the classical DK-Crush, rewiring of the SB generally represented the next step after MB stenting. However, more recently, the use of proximal optimization technique (POT) has been recommended, as in Nano-Crush, where POT facilitates LCx rewiring. Subsequently, both techniques included a type of kissing balloon: Classical for the DK and with snuggle configuration in Nano-Crush. Moreover, the classical DK-Crush technique has been modified introducing a POT as the final step, as in Nano-Crush (Figure 1).

Figure 1
Figure 1 Key steps in the Nano-Crush stenting technique. As both branches are wired (A), both branches are predicated with non-compliant balloons (B) and the stent is deployed at the side branch (C: bench test correlate image). The balloon of the deployed stent is withdrawn and the main branch balloon is inflated in the main branch (MB) at high atmosphere (D); The MB stent of the diameter of the distal reference diameter (3.0 mm) is placed in position and deployed (E: bench test correlate image); Proximal optimization technique (POT) with non-compliant balloon of the same diameter of the MB is performed at high atmosphere (F) and after rewiring of the side branch (G: bench test correlate image), a snuggle kiss is performed with non-compliant balloons (H); Finally, a re-POT is performed with a non-compliant balloon at high atmosphere atm (I: bench test correlate image).

Different from DK-Crush, in which the ostium circumference is completely covered by the SB stent, in the Nano-Crush, the ostium is covered at the carina by the SB stent strut and at the opposite site of the carina by the MB struts opened by the POT into the SB ostium, providing complete circumferential coverage, especially in the case of tight angles, in which the ostium coverage might be incomplete at the carina.

Among these two stenting techniques, one significant difference is represented by the most appropriate stent to implant. In DK-Crush, virtually every kind of stent can be used, while the Nano-Crush has been created to fit with the concept of less metal in the carina, so the ideal stent should have the thinnest struts possible, at least 60 to 80 microns.

TAP or standard T usually leave the SB stent strut floating into the MB; this causes a non-physiologic flow, which may induce lower wall shear stress and turbulent flow, leading to thrombosis and in-stent restenosis[16]. On the other hand, the Culotte usually leaves two or three metal layers into the carina for a length ranging from 5 to 15 mm, even in the “Mini” version.

AMOUNT OF METAL INTO THE CARINA: DOES IT REALLY MATTER?

The lack or excess amount of metal layers at the carina has been suggested to be a potential cause of stent restenosis and thrombosis, respectively[17]. As recently suggested by our group, using computed fluid dynamics, the Culotte and other techniques that leave large amounts of metal at the carina unfavorably impacted the bifurcation rheology, causing an increase in lower wall shear stress (WSS) and in the SB. Indeed, low WSS is a potential substrate for restenosis and thrombosis (Figure 2).

Figure 2
Figure 2 Microcomputed tomography picture of a bifurcation treated by the Nano-Crush technique. A: Region of the carina investigated by computed fluid dynamic showing from the inside of a vessel with high wall shear stress (red zone, white arrows) located at the side branch portion of the carina, which should potentially be in favor of less restenosis and thrombosis at that site; B: Angioscopic image of the same region showing a very smooth transition of the wall at the bifurcation with a very minimal (Nano) apposition of two stent layers. SB: Side branch; MB: Main branch.

To achieve a more physiological flow profile, there should ideally be less metal coverage in the carina side and full metal coverage in the area opposite of the carina and the ostium of the SB. DK-Crush and Nano-Crush are likely to work differently in terms of lowering WSS areas depending on the LM bifurcation. The distribution of metal and the coverage of the carina by the struts strictly depends on the angles: Sharp angles tend to increase the amount of metal at the carina, especially when a generous portion of the SB stent is protruding and should be crushed, whereas if the portion of the stent to be crushed is shorter and the angle is wider, the amount of the metal would be less and coverage might be even incomplete. Obviously, the use of ultra-thin stent struts in DK-Crush or other techniques would potentially improve both safety and long-term outcomes.

STENT ENGINEERING CONSIDERATIONS

The Orsiro (Biotronic AG, BÜlach, Switzerland) stent is considered to have the thinnest struts commercially available. In the most recent European randomized trials, this stent demonstrated a very good safety and efficacy profile. Indeed, its low rate of stent thrombosis reached the non-inferiority statistical significance compared to Xience Prime stent (Abbott Inc., United States)[18-19] with a faster strut endothelium coverage evaluated by optical coherence tomography in respect to the competitors[20]. These results could be achieved even after overcoming the major intrinsic structural limitation to the stent’s design, such as longitudinal shortening[21]. Nowadays, other stents have been designed with similar ultra-thin struts, such as the Resolute Onyx stent by Medtronic Inc. or the Ultimaster by Terumo Inc., which are currently being evaluated in real-world scenarios but promise to maintain the line of their predecessor or do even better in terms of strut neointima coverage.

Nowadays, stent working size in most LMs should not be less than 4.5 mm, and all modern techniques imply the use of POT at high pressure. All of these issues could contribute to stent deformation and polymer rupture, both of which can influence thrombosis and restenosis rates. The availability of thin struts and different sized stents useful to treat LM bifurcation, maintaining a good radial force and minimal shortening will represent a mandatory goal to be accomplished by companies in the market in the near future (Table 2).

Table 2 Thinnest struts stents and their maximum expansion for left main interventions.
Stent typeStrut thickness (μ)Max size achievable (mm)
Orsiro Biotronik, Sui60-805.3 (3.5 stent)
Onyx Medtronic, United States706 (4.0 stent)
Ultimaster Terumo, Japan805.8 (3.5 stent)
Biomime Meril655.3 (4.5 stent)1
Synergy Boston Scientific, United States745.7 (4.0 stent)
THE NEW MANTRA OF LM STENTING

Nowadays, LM stenting has gaining respect as an alternative to surgical treatment[22-24], but the treatment of complex LM disease distal/bifurcation disease remains a significant obstacle to overcome to achieve satisfactory results. In such disease, the double stenting technique would provide a more reliable strategy as supported by the evidence coming from both clinical and virtual studies about the benefits provided by thin strut stent technology.

The modern crush techniques such as DK-Crush and Nano-Crush are providing excellent results on mid and long-term follow up, suggesting that minimal crushing obtained using ultra-thin stents is a good way to obtain surgical-like outcomes in the treatment of complex LM bifurcation disease.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Cardiac and cardiovascular systems

Country of origin: Italy

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C, C

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Vidal-Perez R, Akin I, Barik R S- Editor: Dou Y L- Editor: Filipodia E- Editor: Wu YXJ

References
1.  Behan MW, Holm NR, de Belder AJ, Cockburn J, Erglis A, Curzen NP, Niemelä M, Oldroyd KG, Kervinen K, Kumsars I. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Eur Heart J. 2016;37:1923-1928.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 81]  [Cited by in F6Publishing: 86]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
2.  Hildick-Smith D, Behan MW, Lassen JF, Chieffo A, Lefèvre T, Stankovic G, Burzotta F, Pan M, Ferenc M, Bennett L. The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations. Circ Cardiovasc Interv. 2016;9.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 82]  [Article Influence: 11.7]  [Reference Citation Analysis (0)]
3.  Zhang JJ, Gao XF, Han YL, Kan J, Tao L, Ge Z, Tresukosol D, Lu S, Ma LK, Li F. Treatment effects of systematic two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomised and multicentre DEFINITION II trial. BMJ Open. 2018;8:e020019.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 6]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
4.  Chen SL, Santoso T, Zhang JJ, Ye F, Xu YW, Fu Q, Kan J, Zhang FF, Zhou Y, Xie DJ. Clinical Outcome of Double Kissing Crush Versus Provisional Stenting of Coronary Artery Bifurcation Lesions: The 5-Year Follow-Up Results From a Randomized and Multicenter DKCRUSH-II Study (Randomized Study on Double Kissing Crush Technique Versus Provisional Stenting Technique for Coronary Artery Bifurcation Lesions). Circ Cardiovasc Interv. 2017;10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 62]  [Cited by in F6Publishing: 65]  [Article Influence: 9.3]  [Reference Citation Analysis (1)]
5.  Beier S, Ormiston J, Webster M, Cater J, Norris S, Medrano-Gracia P, Young A, Cowan B. Impact of bifurcation angle and other anatomical characteristics on blood flow - A computational study of non-stented and stented coronary arteries. J Biomech. 2016;49:1570-1582.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 35]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
6.  Ormiston JA, Webster MW, Webber B, Stewart JT, Ruygrok PN, Hatrick RI. The “crush” technique for coronary artery bifurcation stenting: insights from micro-computed tomographic imaging of bench deployments. JACC Cardiovasc Interv. 2008;1:351-357.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 93]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
7.  Chen SL, Sheiban I, Xu B, Jepson N, Paiboon C, Zhang JJ, Ye F, Sansoto T, Kwan TW, Lee M. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts). JACC Cardiovasc Interv. 2014;7:1266-1276.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 114]  [Cited by in F6Publishing: 138]  [Article Influence: 13.8]  [Reference Citation Analysis (0)]
8.  Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, Wu X. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients. BMC Cardiovasc Disord. 2018;18:115.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 36]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
9.  Rab T, Sheiban I, Louvard Y, Sawaya FJ, Zhang JJ, Chen SL. Current Interventions for the Left Main Bifurcation. JACC Cardiovasc Interv. 2017;10:849-865.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 49]  [Article Influence: 7.0]  [Reference Citation Analysis (0)]
10.  Chen SL, Zhang JJ, Han Y, Kan J, Chen L, Qiu C, Jiang T, Tao L, Zeng H, Li L. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. J Am Coll Cardiol. 2017;70:2605-2617.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 173]  [Cited by in F6Publishing: 209]  [Article Influence: 29.9]  [Reference Citation Analysis (0)]
11.  Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ. Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study. JACC Cardiovasc Interv. 2015;8:1335-1342.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 108]  [Cited by in F6Publishing: 112]  [Article Influence: 14.0]  [Reference Citation Analysis (0)]
12.  Rigatelli G, Dell’Avvocata F, Zuin M, Vassiliev D, Mazza A, Dinh HD. Complex coronary bifurcation revascularization by means of very minimal crushing and ultrathin biodegradable polymer DES: Feasibility and 1-year outcomes of the “Nano-crush” technique. Cardiovasc Revasc Med. 2017;18:22-27.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
13.  Rigatelli G, Zuin M, Dell’Avvocata F, Vassilev D, Daggubati R, Nguyen T, Nguyễn MTN, Foin N. Complex coronary bifurcation treatment by a novel stenting technique: Bench test, fluid dynamic study and clinical outcomes. Catheter Cardiovasc Interv. 2018;.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
14.  Rigatelli G, Dell’Avvocata F, Zuin M, Giatti S, Duong K, Pham T, Tuan NS, Vassiliev D, Daggubati R, Nguyen T. Comparative Computed Flow Dynamic Analysis of Different Optimization Techniques in Left Main Either Provisional or Culotte Stenting. J Transl Int Med. 2017;5:205-212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
15.  Colombo A. Bifurcational lesions and the “crush” technique: understanding why it works and why it doesn’t-a kiss is not just a kiss. Catheter Cardiovasc Interv. 2004;63:337-338.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 31]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
16.  Katritsis DG, Theodorakakos A, Pantos I, Gavaises M, Karcanias N, Efstathopoulos EP. Flow patterns at stented coronary bifurcations: computational fluid dynamics analysis. Circ Cardiovasc Interv. 2012;5:530-539.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 46]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
17.  Hu ZY, Chen SL, Zhang JJ, Shan SJ, Liu ZZ, Ye F, Kan J, Xu HM, Nguyen K, Kwan T. Distribution and magnitude of shear stress after coronary bifurcation lesions stenting with the classical crush technique: a new predictor for in-stent restenosis. J Interv Cardiol. 2010;23:330-340.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
18.  Lefèvre T, Haude M, Neumann FJ, Stangl K, Skurk C, Slagboom T, Sabaté M, Goicolea J, Barragan P, Cook S. Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: 5-Year Outcomes of the Randomized BIOFLOW-II Trial. JACC Cardiovasc Interv. 2018;11:995-1002.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 54]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
19.  Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet. 2017;390:1843-1852.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 188]  [Cited by in F6Publishing: 201]  [Article Influence: 28.7]  [Reference Citation Analysis (0)]
20.  Kretov Е, Naryshkin I, Baystrukov V, Grazhdankin I, Prokhorikhin A, Zubarev D, Biryukov A, Verin V, Boykov A, Malaev D, Pokushalov E, Romanov A, Bergmann MW. Three-months optical coherence tomography analysis of a biodegradable polymer, sirolimus-eluting stent. J Interv Cardiol. 2018;31:442-449.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
21.  Guler A, Guler Y, Acar E, Aung SM, Efe SC, Kilicgedik A, Karabay CY, Barutcu S, Tigen MK, Pala S. Clinical, angiographic and procedural characteristics of longitudinal stent deformation. Int J Cardiovasc Imaging. 2016;32:1163-1170.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 14]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
22.  De Rosa S, Polimeni A, Sabatino J, Indolfi C. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis. BMC Cardiovasc Disord. 2017;17:240.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
23.  Campos CM, Christiansen EH, Stone GW, Serruys PW. The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation. EuroIntervention. 2015;11 Suppl V:V115-V119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
24.  Sawaya FJ, Lefèvre T, Chevalier B, Garot P, Hovasse T, Morice MC, Rab T, Louvard Y. Contemporary Approach to Coronary Bifurcation Lesion Treatment. JACC Cardiovasc Interv. 2016;9:1861-1878.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 94]  [Article Influence: 13.4]  [Reference Citation Analysis (1)]